Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Taking Vitamin D Supplements May Not Improve Bone Health

Linda Carroll  |  October 7, 2018

One big issue in studying vitamin D is there is no consensus on what’s a healthy level of the nutrient, Avenell said.

“There’s a lot of disagreement between different bodies producing guidelines around the world,” she added. “Our work would suggest that it’s a lot less than people have thought.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

While the new findings may hold true for the average person, they may be wrong for people whose bones have already thinned, said Dr. Ethel Siris, director of the Toni Stabile Osteoporosis Center at NewYork-Presbyterian/Columbia University Irving Medical Center and a professor of medicine at Columbia University.

“The main reason older women begin to lose bone mass and to have fractures is loss of estrogen at menopause,” Siris said. “A risk factor for it getting worse is low levels of calcium or vitamin D. There’s an argument about how much is needed, but if there’s a bone problem already, you want to make sure you’re adequately covered with respect to calcium and vitamin D.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The risks associated with vitamin D are tiny, Siris said. “And while we’d rather people got their vitamin D through their diet, we will add a pill if necessary. My patients can’t afford to have a vitamin D deficiency.”

The bottom line on the new study, Siris said, “is it’s not changing my point of view with respect to the types of people I take care of.”

Siris said she’s concerned that news about the new research will convince people who already have brittle bones to stop taking their vitamin D supplements. “People read (news stories) about these things and assume what they read yesterday is the current truth,” she added.

Reference

  1. Mark J Bolland, PhD, Andrew Grey, M, Alison Avenell, MD, et al. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. The Lancet. 2018 Oct 4. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30265-1/fulltext

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:Alison Avenellbone densityFracturesOsteoporosisosteoporosis treatmentsvitamin D supplementation

Related Articles

    Drug Updates

    November 1, 2009

    Information on News Approvals and Medication Safety

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

    Vitamin D in Rheumatology: Cause and Effect Unclear

    September 15, 2015

    The controversy over vitamin D is hearty enough to confuse even seasoned rheumatologists, says Nathan Wei, MD, The Arthritis Treatment Center, Frederick, Md. “It’s like what you hear with coffee. One week, [a study finds] coffee is … good for you; the next week, there’s a study saying it’s bad for you,” he says. ad…

    Improve RA Care with Vitamin D

    November 16, 2015

    Background Autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythema­tous, occur when the body attacks its own tissue because it cannot differentiate between self and non-self. This is mainly through deregulation of the immune system. Vitamin D has been known to play a critical role in bone mineralization and bone health. Activated vitamin…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences